A novel strategy against rheumatoid arthritis - European Biotechnology

A novel strategy against rheumatoid arthritis  European Biotechnology

Researchers at AstraZeneca , Viela Bio , Gilead Sciences , Antidote Therapeutics Inc. , and at SoseiHeptares report on a new small molecule compound to treat ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases